Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Controlled Release Année : 2021

Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine

Résumé

Among the numerous nanomedicine formulations, dendrimers have emerged as original, efficient, carefully assembled, hyperbranched, polymeric nanoparticles based on synthetic monomers. Dendrimers are used either as nanocarriers of drugs or as drugs themselves. When used as drug carriers, dendrimers are considered ‘best-in-class agents’, modifying and enhancing the pharmacokinetic and pharmacodynamic properties of the active entities encapsulated or conjugated with the dendrimers. When used as drugs themselves, dendrimers represent a novel category of “first-in-class” drugs. The purpose of this original review is to analyse the different strategies involved in the development, application, and impact of dendrimers as drugs. We examine a selection of nanoparticles that use multifunctional elements and demonstrate clinical multifunctionality, and we extend these principles to applications in dendrimer nanomedicine design. Finally, for practical consideration, the concepts of vertical and diagonal translation are introduced as potential strategies to facilitate dendrimer development.
Fichier principal
Vignette du fichier
S0168365921003795.pdf (1.34 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03657022 , version 1 (02-08-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Serge Mignani, Xiangyang Shi, Keegan Guidolin, Gang Zheng, Andrii Karpus, et al.. Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine. Journal of Controlled Release, 2021, 337, pp.356-370. ⟨10.1016/j.jconrel.2021.07.036⟩. ⟨hal-03657022⟩
30 Consultations
16 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More